Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis - Quiz - MDSpire

Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis

  • By

  • Matthew P. Kosloski

  • Ching-Ha Lai

  • Michael A. Partridge

  • Vanaja Kanamaluru

  • Ashish Bansal

  • Brad Shumel

  • Marius Ardeleanu

  • Hong Yan

  • Christine Xu

  • Ainara Rodríguez Marco

  • Jing Xiao

  • Faisal A. Khokhar

  • Guy Gherardi

  • Elisa Babilonia

  • Bolanle Akinlade

  • Albert Torri

  • John D. Davis

  • April 29, 2026

  • 0 min

Share

Original Source(s)

Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis

  • by Matthew P. Kosloski, Ching-Ha Lai, Michael A. Partridge, Vanaja Kanamaluru, Ashish Bansal, Brad Shumel, Marius Ardeleanu, Hong Yan, Christine Xu, Ainara Rodríguez Marco, Jing Xiao, Faisal A. Khokhar, Guy Gherardi, Elisa Babilonia, Bolanle Akinlade, Albert Torri, John D. Davis

  • April 29, 2026

Related Content

Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments

Oral TYK2 Inhibition in Atopic Dermatitis

Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.